Two Sigma Advisers’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-243,793
| Closed | -$329K | – | 3017 |
|
|
2021
Q4 | $329K | Buy |
243,793
+48,500
| +25% | +$65.5K | ﹤0.01% | 2112 |
|
|
2021
Q3 | $568K | Sell |
195,293
-453,200
| -70% | -$1.32M | ﹤0.01% | 1873 |
|
|
2021
Q2 | $2.26M | Buy |
648,493
+7,300
| +1% | +$25.5K | 0.01% | 1235 |
|
|
2021
Q1 | $2.19M | Buy |
641,193
+212,700
| +50% | +$727K | 0.01% | 1222 |
|
|
2020
Q4 | $8.23M | Buy |
428,493
+255,800
| +148% | +$4.91M | 0.02% | 641 |
|
|
2020
Q3 | $2.32M | Buy |
172,693
+147,000
| +572% | +$1.97M | 0.01% | 1082 |
|
|
2020
Q2 | $1.09M | Sell |
25,693
-700
| -3% | -$29.6K | ﹤0.01% | 1537 |
|
|
2020
Q1 | $729K | Buy |
26,393
+600
| +2% | +$16.6K | ﹤0.01% | 1638 |
|
|
2019
Q4 | $837K | Buy |
25,793
+4,800
| +23% | +$156K | ﹤0.01% | 1657 |
|
|
2019
Q3 | $546K | Buy |
+20,993
| New | +$546K | ﹤0.01% | 1684 |
|